Dr. L.J. van 't Veer

Pagina-navigatie:

filter results

Date

Accessibility

Institution

1-2 out of 2 results by:date

Save search results

Benefit of the 70-gene profile for widely used guidelines: an answer to increased selection for adjuvant chemotherapy in breast cancer (Poster) (2008)Open access

Authors: Knauer, Michael; Retèl, V.; Bueno-de-Mesquita, J.M.; Rutgers, E.J.T.; Harten, van W.H.; Rodenhuis, S.; Vijver, van de M.J.; Veer, van 't L.J.; Linn, S.C.

Abstract:
Risk assessment for breast cancer patients differs substantially among treatment guidelines. The NCCN, St.Gallen, Adjuvant!Online, and Dutch 2008 guidelines are less restrictive in comparison to the 2004 Dutch guidelines and Nottingham Prognostic Index, when selecting patients for adjuvant systemic
Implementation assessment of the 70-gene prognosis signature for breast cancer diagnostics (Poster) (2008)Open access

Authors: Retèl, V.P.; Bueno-de-Mesquita, J.M.; Veer, van 't L.; Vijver, van de M.J.; Hummel, M.J.M.; Linn, S.C.; Harten, van W.H.